[Vasoprotective effect of effective lipid-lowering therapy in patients with
ST-segment elevation myocardial infarction
arterial stiffness
atorvastatin
Journal
Terapevticheskii arkhiv
ISSN: 0040-3660
Titre abrégé: Ter Arkh
Pays: Russia (Federation)
ID NLM: 2984818R
Informations de publication
Date de publication:
16 Jan 2023
16 Jan 2023
Historique:
received:
07
08
2021
medline:
15
5
2023
pubmed:
11
5
2023
entrez:
11
5
2023
Statut:
epublish
Résumé
To study the vasoprotective effects of atorvastatin depending on the achievement of the target level of low-density lipoprotein cholesterol (LDL-C) in patients with Included were 112 When examining the carotid arteries in the HET group, the intima-media thickness (IMT) decreased by 10.7-13.1%, the b index - by 14.9-26.3% after 24-48 weeks. In the RET group, the IMT regression was 10.4-13.3%; b index - 23.9% by the 48th week. In the IET group, the b index decreased by the 48th week by 14.3%. According to applanation tonometry in the HET group, the central pressure did not change. In the RET group, systolic pressure in the aorta increased by 10-15.7% after 24-48 weeks, pulse pressure - by 33.9% by the end of observation. With IET, the increase was 8.6-6.8 and 19.8-25.9%, respectively. The odds ratio of developing endpoints in the RET group was 4.7 (95% CI 1.2-26.4; The most pronounced vasoprotective effect and a decrease in cardiovascular risk are associated with the achievement of the target LDL-C throughout the entire treatment period. Цель. Изучить вазопротективные эффекты аторвастатина в зависимости от достижения целевого уровня холестерина липопротеидов низкой плотности (ХС ЛНП) у больных с инфарктом миокарда с подъемом сегмента
Autres résumés
Type: Publisher
(rus)
Цель. Изучить вазопротективные эффекты аторвастатина в зависимости от достижения целевого уровня холестерина липопротеидов низкой плотности (ХС ЛНП) у больных с инфарктом миокарда с подъемом сегмента
Identifiants
pubmed: 37167178
doi: 10.26442/00403660.2022.12.202007
doi:
Substances chimiques
Atorvastatin
A0JWA85V8F
Cholesterol, LDL
0
Types de publication
English Abstract
Journal Article
Langues
rus
Sous-ensembles de citation
IM